## HIGH DOSE METHOTREXATE – High risk (Group C) - CNS positive 

(High dose MTX for CNS positive patients only – between CYVE1 and CYVE2)

Around day 18 when ANC > 0.5 x 109/L and platelets > 50 x 109/L and 48 hrs after the last injection of G-CSF and/or platelet transfusion. 

**High Dose Methotrexate (DM)**
-	Route: IV over 4 hours
-	Dosage: 8 g/m2/dose, diluted in 250ml, infusion NS over 4 hours
-	Used on Day 1
-	Caution: IV folinic 15 mg/m2/dose every 6 hourly x 4 doses starting at 24 hrs after start of IV MTX and continue until MTX level is < 0.1 uM.
-	Important note: For CNS positive only Day 18 from start CYVE#1

**Triple Intrathecal (TIT)**

Triple intrathecal (IT) therapy doses, according to patient age, are as follows:

-	For patients under 1 year of age, administer methotrexate 8 mg, hydrocortisone 8 mg, and cytarabine 16 mg, in a total volume of 3 mL.
-	For patients aged 1 to 2 years, administer methotrexate 10 mg, hydrocortisone 10 mg, and cytarabine 20 mg, in a total volume of 4 mL.
-	For patients aged 2 to 3 years, administer methotrexate 12 mg, hydrocortisone 12 mg, and cytarabine 24 mg, in a total volume of 5 mL.
-	For patients older than 3 years, administer methotrexate 15 mg, hydrocortisone 15 mg, and cytarabine 30 mg, in a total volume of 6 mL.
-	These doses are to be given only on Day 1
-	Should be given before folinic acid is started.

